US.DVA · DaVita

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 4.4366572237960336,
        "turnoverUsdM": 194.582778,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DVA",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 160.8386,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.9,
      "take_profit_price": 191.3783,
      "target_multiplier": 1.9,
      "technical_strength": 1.5,
      "take_profit_percent": 8.4
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.873314447592067,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 54.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 48.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 6
  },
  "market": {
    "ma20": 196.7185,
    "ma50": 213.85,
    "close": 176.5,
    "prevClose": 173.82,
    "avgVolume20": 1044268,
    "volumeRatio": 1.06,
    "changePercent": 1.54
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 6,
    "details": {
      "ret_5d": -0.0011318619128465324,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 6,
      "vcp_bonus": 0,
      "vol_ratio": 1.0803904274710414,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.9671710073507908,
      "volat_points": 0,
      "day_range_pct": 0.032634617563739345,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 54.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 1.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 34,
        "contribution": 1.7
      },
      {
        "raw": 8.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 42,
        "contribution": 8.4
      },
      {
        "raw": 7,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 46.67,
        "contribution": 7
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 5.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 57,
        "contribution": 5.7
      },
      {
        "raw": 11.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 39,
        "contribution": 11.7
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 48.5,
    "details": [
      "基本面分析總分: 1.7/5分",
      "資金流分析總分: 8.4/20分",
      "市場環境分析總分: 7/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 5.7/10分",
      "技術信號分析總分: 11.7/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 1.7,
      "資金流": 8.4,
      "市場環境": 7,
      "情緒分析": 8,
      "技術信號": 11.7,
      "風險管理": 5.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.3,
          "marginPoints": 0,
          "turnoverUsdM": 194.582778,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DVA",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.13
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 710.3985018500001,
                "ma50": 713.2256020399999,
                "name": "QQQ",
                "close": 706.32001,
                "points": 0.4
              },
              "spy": {
                "ma20": 763.5459993000001,
                "ma50": 752.2638036,
                "name": "SPY",
                "close": 763.46997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.4366572237960336,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 6,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141196726,
                "url": "https://finnhub.io/api/news?id=48e8509d37250a13894438aabf8983d64432adb6850d09c9250418e8fd2de506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Mortality gains drove treatment growth despite payor mix headwinds.",
                "category": "company",
                "datetime": 1786492717,
                "headline": "DaVita (DVA) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141159113,
                "url": "https://finnhub.io/api/news?id=89fb50ce25b423f54dbf0e6efa06f0588cf7a38ca41bc2d6e8e54e35db01bf87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita stock has climbed 69.6% over the past three years. After a recent pullback and a strong value score, the current price still raises questions about how much upside investors are actually paying for. Over the past 3 years, DaVita has returned 69.6%, which puts recent share price weakness in the context of a longer period of strong gains. Support for the valuation can come from expectations that DaVita benefits from growing demand for integrated kidney and metabolic care. Execution...",
                "category": "company",
                "datetime": 1786202000,
                "headline": "DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat"
              },
              {
                "id": 141154584,
                "url": "https://finnhub.io/api/news?id=012a4b594bea4cdad34824d5ce20b00004979ffccf14c71e3d283973fcc98787",
                "image": "",
                "source": "Fintel",
                "related": "DVA",
                "summary": "",
                "category": "company",
                "datetime": 1786149813,
                "headline": "TD Cowen Upgrades DaVita (DVA)"
              },
              {
                "id": 141135763,
                "url": "https://finnhub.io/api/news?id=e6b61eb26ca4e796db9cdcde0537e0aaa085377351bf6fedba01057f6ede6d18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1786023603,
                "headline": "Is DaVita (DVA) a Great Value Stock Right Now?"
              },
              {
                "id": 141122819,
                "url": "https://finnhub.io/api/news?id=1207180287dd71d2a309e0350ed4fdb13d7b7fdb160b247c552f49976244764c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita's Q2 earnings call highlights mortality-led volume gains and broader middle molecule access, while management held 2026 guidance amid reimbursement pressure.",
                "category": "company",
                "datetime": 1785938400,
                "headline": "DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth"
              },
              {
                "id": 141118810,
                "url": "https://finnhub.io/api/news?id=9239ac1e5a4d98faa50bdc123077f238d70ea0efb639aabfca73157de2aa204b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita Inc (DVA) reports adjusted EPS of $4.02 and reaffirms full-year guidance amid successful phosphate binder transition and expanded HD dialyzer rollout.",
                "category": "company",
                "datetime": 1785906181,
                "headline": "DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ..."
              },
              {
                "id": 141117611,
                "url": "https://finnhub.io/api/news?id=ccec253f53bb48757db10de4e5ec4ffc0326aa497a0d9e27901b6baf051a5e17",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "DaVita (DVA) reported Q2 2026 earnings with EPS of $4.02 topping estimates, but revenue of $3.55B matched expectations, sending shares down 7.5%.",
                "category": "company",
                "datetime": 1785889044,
                "headline": "DaVita (NYSE:DVA) Q2 2026: EPS Beats, Revenue In Line, Shares Fall 7.5%"
              },
              {
                "id": 141116600,
                "url": "https://finnhub.io/api/news?id=f1a58f4a5cc53cc261e6b343167d7c0f4bdea928c54bdd5bcee60692a1256e8f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) delivered earnings and revenue surprises of +0.25% and +0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785879605,
                "headline": "DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates"
              }
            ],
            "raw_source": [
              {
                "id": 141286519,
                "url": "https://finnhub.io/api/news?id=67f152bf561809429a189bf7214a935dfbcaace2e158b7564e8e3697cae69a22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Throughout DaVita's 25+ year history, we've led the way in patient-centered kidney care. Our work has played a key role in reducing hospitalizations, extending lifespan and helping propel the kidney ...",
                "category": "company",
                "datetime": 1787063700,
                "headline": "Forever Committed to Excellence in Care: DaVita Community Care Report 2025"
              },
              {
                "id": 141279390,
                "url": "https://finnhub.io/api/news?id=11c28671145d7e059f830636157b154b4a20836d59db15978452d3af5ca51504",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Berkshire Hathaway (BRK-A, BRK-B), under new CEO Greg Abel, increased its Alphabet position, making the Google parent its third-largest U.S.-listed equity holding by market value, behind Apple (AAPL) and American Express (AXP). According to a new filing, Berkshire held roughly 106 million Alphabet shares, valued at $37.9 billion, as of the end of June. Recent reporting confirms Berkshire invested about $10 billion in Alphabet during the second quarter.",
                "category": "company",
                "datetime": 1786746540,
                "headline": "Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding"
              },
              {
                "id": 141221695,
                "url": "https://finnhub.io/api/news?id=33980d481653f1b2744dbcdd97bcaaae9cf1b3c206c49090c7306b1bc7f84038",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "Berkshire Hathaway’s Q2 2026 13F: portfolio hits ~$299B as Buffett adds Alphabet & trims BAC—see top holdings, key moves, and buyback details now.",
                "category": "company",
                "datetime": 1786743725,
                "headline": "Tracking Berkshire Hathaway Portfolio - Q2 2026 Update"
              },
              {
                "id": 141220316,
                "url": "https://finnhub.io/api/news?id=0b9671379d55fc25ee61a6bd288d9e98541a519d7f347ba6c91d9094b4b47efe",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/14/The-Berkshire-Hathaway-Logo-Appears-On-A.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Berkshire Hathaway Q2 holdings shows new names and changes to old positions. Here's the list of changes and the top 10 holdings.",
                "category": "company",
                "datetime": 1786725896,
                "headline": "Berkshire Hathaway Doubles Down on Homebuilders, Makes Alphabet Top 3 Holding"
              },
              {
                "id": 141286520,
                "url": "https://finnhub.io/api/news?id=3c050cd5f089e634f513e75a7667b8e3beccedbd02dda52af8f97454ebc2f469",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 14, 2026 / With more than 90,000 people in the U.S. on the national transplant waitlist, the demand for life-saving organs far outpaces the supply. Living donation offers a strong pathway to addressing this ...",
                "category": "company",
                "datetime": 1786718100,
                "headline": "Strengthening the Transplant System: 5 Common Myths About Living Kidney Donation"
              },
              {
                "id": 141202815,
                "url": "https://finnhub.io/api/news?id=66e54523c147f2468167c662c97988af9b6b8add651c2205d0d18ca5f8fda126",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita’s second quarter results surpassed Wall Street’s revenue and adjusted profit expectations, but the market response was notably negative. Management attributed this to a mix of operational and industry-specific challenges, including flat treatment volumes and sequential declines in revenue per treatment, primarily due to a less favorable commercial mix and reduced revenue from phosphate binders. CEO Javier Rodriguez emphasized, “Our growth is mainly performance clinical—that expands life,",
                "category": "company",
                "datetime": 1786596780,
                "headline": "The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call"
              },
              {
                "id": 141196735,
                "url": "https://finnhub.io/api/news?id=9b56e877651c1fc3735f68b126cbb7eccfd93bbb22227236f1bab893ddc103ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "(Bloomberg) -- The latest reason to worry about the stock market is quite the doozy: Earnings growth has been too strong. Most Read from BloombergPhoebe Gates Knew Phia Shopping App Took Credit for Sales It Didn’t DriveTrump Weighs Call for Capital Gains Tax Cuts as Midterm BoostTata Sons Chairman to Step Down, Deepening Leadership TurmoilFive Takeaways From Zuckerberg’s 6,500-Word Manifesto on AIEpstein Victim Files Cleared for Release Over Maxwell’s ProtestAs the latest reporting season nears",
                "category": "company",
                "datetime": 1786545937,
                "headline": "S&P 500 Earnings Are So Good Investors Are Starting to Worry"
              },
              {
                "id": 141196736,
                "url": "https://finnhub.io/api/news?id=12e997e8baa5b0a91989477b8fa3f8f02073d93f772247df8f968ff5badd4add",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 12, 2026 /Working Together, Working for Better At DaVita, people are the foundation of our community and the driving force behind our pursuit of a healthier tomorrow for all. Rooted in our identity as a community ...",
                "category": "company",
                "datetime": 1786541700,
                "headline": "DaVita Community Care Report 2025: Creating a Culture of Belonging for All"
              },
              {
                "id": 141196726,
                "url": "https://finnhub.io/api/news?id=48e8509d37250a13894438aabf8983d64432adb6850d09c9250418e8fd2de506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Mortality gains drove treatment growth despite payor mix headwinds.",
                "category": "company",
                "datetime": 1786492717,
                "headline": "DaVita (DVA) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141196727,
                "url": "https://finnhub.io/api/news?id=6e037e73d88f840a49b07d3a3024729a58a646a0488a2ac88a8fbe078e6a0b54",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Though DaVita has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.",
                "category": "company",
                "datetime": 1786459921,
                "headline": "Are Wall Street Analysts Bullish on DaVita Stock?"
              },
              {
                "id": 141159113,
                "url": "https://finnhub.io/api/news?id=89fb50ce25b423f54dbf0e6efa06f0588cf7a38ca41bc2d6e8e54e35db01bf87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita stock has climbed 69.6% over the past three years. After a recent pullback and a strong value score, the current price still raises questions about how much upside investors are actually paying for. Over the past 3 years, DaVita has returned 69.6%, which puts recent share price weakness in the context of a longer period of strong gains. Support for the valuation can come from expectations that DaVita benefits from growing demand for integrated kidney and metabolic care. Execution...",
                "category": "company",
                "datetime": 1786202000,
                "headline": "DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat"
              },
              {
                "id": 141154584,
                "url": "https://finnhub.io/api/news?id=012a4b594bea4cdad34824d5ce20b00004979ffccf14c71e3d283973fcc98787",
                "image": "",
                "source": "Fintel",
                "related": "DVA",
                "summary": "",
                "category": "company",
                "datetime": 1786149813,
                "headline": "TD Cowen Upgrades DaVita (DVA)"
              },
              {
                "id": 141152305,
                "url": "https://finnhub.io/api/news?id=70ff74ca81dca056505cb3b891e51d5f0f8280764c5a30f8a342a016e1d88fbc",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "TD Cowen  analyst Ryan Langston   upgrades DaVita (NYSE:DVA) from Hold to Buy and lowers the price target from $201 to $220.",
                "category": "company",
                "datetime": 1786120492,
                "headline": "TD Cowen Upgrades DaVita to Buy, Lowers Price Target to $220"
              },
              {
                "id": 141150897,
                "url": "https://finnhub.io/api/news?id=ffe919333b39a4784c80efe3fd541bb87c4541a057dc8d5a69516d91906efc9c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/Green-Bullish-Chart.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "US payrolls shrank by 23K in July. Here is how weak jobs data sparked gains for tech, gold, and top weekly movers.",
                "category": "company",
                "datetime": 1786117202,
                "headline": "The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week"
              },
              {
                "id": 141146420,
                "url": "https://finnhub.io/api/news?id=ea0046566ff293d0f4dac5390a0a00402ccd0a1ef57006eb6d92417c515f6f3f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare Partners Inc. (NYSE:DVA) shares gained around 2.",
                "category": "company",
                "datetime": 1786098854,
                "headline": "DaVita Shares Rise After TD Cowen Upgrades Stock to Buy"
              },
              {
                "id": 141152307,
                "url": "https://finnhub.io/api/news?id=2b956bbebe63065663c6b5887be5da3d57fc0e24ffd5f12e7e443dc67ffab79c",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Truist Securities  analyst David Macdonald   maintains DaVita (NYSE:DVA) with a Hold and lowers the price target from $250 to $215.",
                "category": "company",
                "datetime": 1786094131,
                "headline": "Truist Securities Maintains Hold on DaVita, Lowers Price Target to $215"
              },
              {
                "id": 141135763,
                "url": "https://finnhub.io/api/news?id=e6b61eb26ca4e796db9cdcde0537e0aaa085377351bf6fedba01057f6ede6d18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1786023603,
                "headline": "Is DaVita (DVA) a Great Value Stock Right Now?"
              },
              {
                "id": 141125293,
                "url": "https://finnhub.io/api/news?id=812b1f7f2b3536c413608c3cacf20a3e7da1e3fa13339e3a8e88c45df16a3269",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785956701,
                "headline": "Wednesday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141125946,
                "url": "https://finnhub.io/api/news?id=2f965def36b0f4573fda793bfc3ae5acff4f9e2ecca49602cee05d719f3fda89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA's second-quarter 2026 results show profit growth, but narrowing margins and a weaker commercial mix weigh on the performance.",
                "category": "company",
                "datetime": 1785953100,
                "headline": "DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down"
              },
              {
                "id": 141123471,
                "url": "https://finnhub.io/api/news?id=d76e7dff95c6b1f2ab3eec4aeef8f0996262f2a3cd080007be3ff36d529d15d1",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "Let's have a look at the S&P500 stocks with an unusual volume in today's session.",
                "category": "company",
                "datetime": 1785949500,
                "headline": "These S&P500 stocks have an unusual volume in today's session"
              },
              {
                "id": 141123271,
                "url": "https://finnhub.io/api/news?id=41596b07c037fe81a6963035041969d9a5305c9b2c7c1ef2d76aaea6efc80395",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.",
                "category": "company",
                "datetime": 1785947701,
                "headline": "Top S&P500 movers in Wednesday's session"
              },
              {
                "id": 141121867,
                "url": "https://finnhub.io/api/news?id=6beb908ae12813dfd98a52eb52bb2db4a5234cb5fae50594bf2bc304a6172d38",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1785940501,
                "headline": "Which S&P500 stocks are gapping on Wednesday?"
              },
              {
                "id": 141124772,
                "url": "https://finnhub.io/api/news?id=1db0cc6302bebe93b61e5eb9d2a4357679405616901a47c4a140ddf7ad352f6e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Digital-Gold-Price-Stock-Market-Trading-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.",
                "category": "company",
                "datetime": 1785939260,
                "headline": "Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today"
              },
              {
                "id": 141122819,
                "url": "https://finnhub.io/api/news?id=1207180287dd71d2a309e0350ed4fdb13d7b7fdb160b247c552f49976244764c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita's Q2 earnings call highlights mortality-led volume gains and broader middle molecule access, while management held 2026 guidance amid reimbursement pressure.",
                "category": "company",
                "datetime": 1785938400,
                "headline": "DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth"
              },
              {
                "id": 141120805,
                "url": "https://finnhub.io/api/news?id=c7bd52b475fb75372a286906251e0256b3c53c47c1e6c7d37dbd30857513f8f1",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.",
                "category": "company",
                "datetime": 1785933301,
                "headline": "Wondering what's happening in today's S&P500  pre-market session?"
              },
              {
                "id": 141121495,
                "url": "https://finnhub.io/api/news?id=a68b8ac397ff03a24d668fd0cfe2602d8e6cc648aad8d9c46b6ee7c409445cbf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 5, 2026 / While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested ...",
                "category": "company",
                "datetime": 1785933300,
                "headline": "Beyond the Clinical: How Social Workers Drive Kidney Transplant Success"
              },
              {
                "id": 141133423,
                "url": "https://finnhub.io/api/news?id=0b0c7f9c2c12771c7b984970febe964bd9ae9ac8c8e8060a2c9aad33ca1a4646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Moby summary of DaVita Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785933000,
                "headline": "DaVita Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141122005,
                "url": "https://finnhub.io/api/news?id=7b3709561b5889d15702fa2f2d6fe3b5cfbce80e5d6eeb293d5969cf5b1da1fe",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Konskie--Poland---December-02--2024-Toas.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.",
                "category": "company",
                "datetime": 1785917648,
                "headline": "Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 141121745,
                "url": "https://finnhub.io/api/news?id=03f7d734cf859f037086d60bbd2052457515bd8819b180a68d9627271cdfb27e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/SpaceX.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks also decline.",
                "category": "company",
                "datetime": 1785916986,
                "headline": "SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session"
              },
              {
                "id": 141128725,
                "url": "https://finnhub.io/api/news?id=5d83c685ace0068eec8f342d6d33ba010026b6133e0c431d3d3789075acae60c",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "Barclays  analyst Andrew Mok   maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $218 to $224.",
                "category": "company",
                "datetime": 1785913887,
                "headline": "Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $224"
              },
              {
                "id": 141119304,
                "url": "https://finnhub.io/api/news?id=e2a1da11a0104e0cdec879838e093df67271aeb88dba7a7e6adbec07a3b1b455",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita (NYSE:DVA) reported second-quarter results that management said were broadly in line with expectations, supported by accelerating treatment-volume growth and lower mortality among patients. The kidney-care company reaffirmed its full-year 2026 guidance, while outlining plans to expand access",
                "category": "company",
                "datetime": 1785909831,
                "headline": "DaVita Q2 Earnings Call Highlights"
              },
              {
                "id": 141118810,
                "url": "https://finnhub.io/api/news?id=9239ac1e5a4d98faa50bdc123077f238d70ea0efb639aabfca73157de2aa204b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita Inc (DVA) reports adjusted EPS of $4.02 and reaffirms full-year guidance amid successful phosphate binder transition and expanded HD dialyzer rollout.",
                "category": "company",
                "datetime": 1785906181,
                "headline": "DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ..."
              },
              {
                "id": 141117611,
                "url": "https://finnhub.io/api/news?id=ccec253f53bb48757db10de4e5ec4ffc0326aa497a0d9e27901b6baf051a5e17",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "DaVita (DVA) reported Q2 2026 earnings with EPS of $4.02 topping estimates, but revenue of $3.55B matched expectations, sending shares down 7.5%.",
                "category": "company",
                "datetime": 1785889044,
                "headline": "DaVita (NYSE:DVA) Q2 2026: EPS Beats, Revenue In Line, Shares Fall 7.5%"
              },
              {
                "id": 141116600,
                "url": "https://finnhub.io/api/news?id=f1a58f4a5cc53cc261e6b343167d7c0f4bdea928c54bdd5bcee60692a1256e8f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita HealthCare (DVA) delivered earnings and revenue surprises of +0.25% and +0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785879605,
                "headline": "DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141117020,
                "url": "https://finnhub.io/api/news?id=cfec4c40b41fce868b61126ad3d72f45264becd28d0c2e009d474b93ae590ac2",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "DaVita Inc. (DVA) Q2 2026 Earnings Call August 4, 2026 5:00 PM EDTCompany ParticipantsNic Eliason - Group Vice President of Investor RelationsJavier...",
                "category": "company",
                "datetime": 1785877801,
                "headline": "DaVita Inc. (DVA) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141115212,
                "url": "https://finnhub.io/api/news?id=c030ebde4b05a94dcd4f3ceef980c30f38a230d5866887da8cfabd173dc8e45e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2026, with sales up 5.2% year on year to $3.55 billion. Its non-GAAP profit of $4.02 per share was 3.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785877570,
                "headline": "DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops"
              },
              {
                "id": 141114398,
                "url": "https://finnhub.io/api/news?id=128748e70fd448792fef6acf53a13fb9d27611d701ce9536719aad3e2e90eec4",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.",
                "category": "company",
                "datetime": 1785877501,
                "headline": "Discover the top S&P500 movers in Tuesday's after-hours session."
              },
              {
                "id": 141115213,
                "url": "https://finnhub.io/api/news?id=126879a181282093c70bb55db83d59adade4b0836d3822d4b4d8d5a4d3103eea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2026.",
                "category": "company",
                "datetime": 1785873900,
                "headline": "DaVita Inc. 2nd Quarter 2026 Results"
              },
              {
                "id": 141116318,
                "url": "https://finnhub.io/api/news?id=8bf6acfee8999c4d33027920bcb9df5a6d899d4d90f23bf2969bd4c1255bd351",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "- SEC Filing",
                "category": "company",
                "datetime": 1785865408,
                "headline": "DaVita Form4 Filing Shows Berkshire Hathaway Sells 182,980 Davita Shares At An Average $199.55/Share, Still Owns About 28.7M Shares"
              },
              {
                "id": 141110958,
                "url": "https://finnhub.io/api/news?id=4e793c422f218ab62d1164c67ac396d7cb3fce207320af07b0c12abd4c466a02",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "DVA",
                "summary": "Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.",
                "category": "company",
                "datetime": 1785863100,
                "headline": "Which S&P500 stocks have an unusual volume on Tuesday?"
              },
              {
                "id": 141123555,
                "url": "https://finnhub.io/api/news?id=df75621594f5de94fc6b7fbd72d4a1668a3d92055b31237ab5306644e918ba6a",
                "image": "https://image.cnbcfm.com/api/v1/image/108320946-17812664072026-06-12t013236z_1315905691_rc20slaz2827_rtrmadp_0_spacex-ipo-starbase.jpeg?v=1781266476&w=1920&h=1080",
                "source": "CNBC",
                "related": "DVA",
                "summary": "These are the stocks posting the largest moves after the bell.",
                "category": "company",
                "datetime": 1785862394,
                "headline": "Stocks making the biggest moves after the bell: SpaceX, AMD, Pinterest, Arista Networks, Wynn Resorts & more"
              },
              {
                "id": 141116319,
                "url": "https://finnhub.io/api/news?id=92a2b4cc15f1696b369c7105a1234af0fd22c6a64bc7bf7871e785aa61548bb1",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "DaVita (NYSE:DVA) affirms FY2026 Adj EPS guidance from $14.10-$15.20 to $14.10-$15.20 vs $14.82 analyst estimate..",
                "category": "company",
                "datetime": 1785859626,
                "headline": "DaVita Affirms FY2026 Adj EPS Guidance of $14.10-$15.20 vs $14.82 Est"
              },
              {
                "id": 141116320,
                "url": "https://finnhub.io/api/news?id=92233ad469ae974b117331c705662a39d27e992a6e5bb58badbb856c355d045b",
                "image": "",
                "source": "Benzinga",
                "related": "DVA",
                "summary": "DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $3.88 by 3.61 percent. This is a 36.27 percent increase over earnings of $2.95 per share from the same period",
                "category": "company",
                "datetime": 1785859591,
                "headline": "DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate"
              },
              {
                "id": 141108989,
                "url": "https://finnhub.io/api/news?id=842c85a6949d89bcdfce85bdf15a56691f620ce4bc6bfe0e2b15e0d7dd707f07",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / August 4, 2026 / DaVita Commitments in Action Community Partnerships for Health In 2025, DaVita expanded its work with the YMCA to support chronic kidney disease (CKD) education and prevention. Focused on promoting ...",
                "category": "company",
                "datetime": 1785846900,
                "headline": "DaVita Community Care Report 2025 : The Value of Community-Based Health Screenings"
              },
              {
                "id": 141102762,
                "url": "https://finnhub.io/api/news?id=1bf8c6458c718c98c45171ca70adba3f4e1fe6b3deedcaed08f104bb3915a2d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "The VistaShares Target 15 Berkshire Select Income ETF has topped Berkshire stock’s return of 3% since March 2025.",
                "category": "company",
                "datetime": 1785787560,
                "headline": "Buffett-Inspired ETF Owns Berkshire, Apple, Amex and Generates 15% Yield"
              },
              {
                "id": 141101313,
                "url": "https://finnhub.io/api/news?id=2f4bf403bcb2cd0edae3326ef4375ce5508bba9810928ea46cc99b01e0418234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA's Q2 results are likely to benefit from volume growth and RPT recovery, but payor mix pressure and spending on technology could limit margin gains.",
                "category": "company",
                "datetime": 1785775740,
                "headline": "Can Volume Growth and RPT Recovery Support DaVita's Q2 Earnings?"
              },
              {
                "id": 141101314,
                "url": "https://finnhub.io/api/news?id=173ee8de99bacbb1708d04dec97162dc07333e8acb8eae4de5c89d9eb3706037",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting earnings this Tuesday afternoon. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785768322,
                "headline": "DaVita (DVA) Reports Q2: Everything You Need To Know Ahead Of Earnings"
              },
              {
                "id": 141101207,
                "url": "https://finnhub.io/api/news?id=ab4db3f301def98b9f07aa9343c6e7daf76ba96dee31f403cc70a8426f9e6464",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DGX raised its 2026 outlook as testing demand surged, but lower-margin deals and rising project costs could temper the payoff.",
                "category": "company",
                "datetime": 1785767820,
                "headline": "Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates"
              },
              {
                "id": 141079209,
                "url": "https://finnhub.io/api/news?id=a6471e0133a67e636ec4594009b47f90824127b7b349df3ce876842b2945e378",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Quest Diagnostics' earnings beat, raised 2026 outlook and broad testing demand support momentum, but valuation, debt and margin pressure temper the buy case.",
                "category": "company",
                "datetime": 1785506760,
                "headline": "Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?"
              },
              {
                "id": 141068616,
                "url": "https://finnhub.io/api/news?id=40b44f41e63b7857e9e36a8644fb6508a1c4e9f44f4936c01762e026d58a57b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DGX's broad testing demand, payer access, advanced diagnostics and partnerships support 2026 growth as AI and automation target costs.",
                "category": "company",
                "datetime": 1785429240,
                "headline": "Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026"
              },
              {
                "id": 141065804,
                "url": "https://finnhub.io/api/news?id=ad7004e4621b9bc43f368316fb6321769b80f6b32bd615999f35db0fec5eb841",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / July 30, 2026 / For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also ...",
                "category": "company",
                "datetime": 1785414900,
                "headline": "Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems"
              },
              {
                "id": 141063998,
                "url": "https://finnhub.io/api/news?id=59ba127b3f6b9aabeb9639f480050484114f7ca2e9e1b26b621b661cfe2d5e58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DaVita’s modeled fair value has shifted from US$193.71 to US$208.57, signaling a fresh round of updated price targets that investors are watching closely. Recent analyst commentary has taken a mixed but generally constructive tone, with higher targets often linked to DaVita’s growth investments, technology efforts, and focus on patient outcomes. As you read on, you will see how these changing targets fit into the broader DaVita story and what to monitor as the narrative evolves. Analyst Price...",
                "category": "company",
                "datetime": 1785402520,
                "headline": "DaVita (DVA) Stock Sees Fair Value Lift After Analyst Target Increases"
              },
              {
                "id": 141055863,
                "url": "https://finnhub.io/api/news?id=dc6b208f3d8cb61b19b3c297a8cc56c2951996a4af7af738c66e92cd98982229",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.",
                "category": "company",
                "datetime": 1785337380,
                "headline": "Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"
              },
              {
                "id": 141054623,
                "url": "https://finnhub.io/api/news?id=827bfc7ea67d2086982bd64a0484ca1b01c6eb5a356610baf98a6beaae34021b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "Xeltis recently secured an additional €20.5 million in funding led by Horizon 3 Healthcare, with DaVita participating to help advance the aXess™ vascular access platform through US trials, regulatory submissions, and European rollout. Alongside this investment, investor attention has intensified around DaVita’s upcoming August 2026 earnings report and its initiatives to expand equitable access to kidney care, including home dialysis and transplant support. With DaVita’s recent returns in...",
                "category": "company",
                "datetime": 1785334142,
                "headline": "How Xeltis Partnership And Kidney Care Initiatives Could Shape DaVita’s (DVA) Long-Term Care Strategy"
              },
              {
                "id": 141050716,
                "url": "https://finnhub.io/api/news?id=acf31ea34dcd802d0fba9bc5526ffc05d8fde53540c7fa0b4510a7d7042515df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "What a time it’s been for DaVita. In the past six months alone, the company’s stock price has increased by a massive 122%, reaching $235.17 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1785305102,
                "headline": "DaVita (DVA): Buy, Sell, or Hold Post Q1 Earnings?"
              },
              {
                "id": 141048436,
                "url": "https://finnhub.io/api/news?id=a26cf1e5ebc30162f711d6570899240b9cce07a4f0f5dbe307583db7d2680b59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "In the latest trading session, DaVita HealthCare (DVA) closed at $239.46, marking a +1.33% move from the previous day.",
                "category": "company",
                "datetime": 1785276005,
                "headline": "Why DaVita HealthCare (DVA) Outpaced the Stock Market Today"
              },
              {
                "id": 141044156,
                "url": "https://finnhub.io/api/news?id=f297ada419289e690b1bfd00b9d05ed5a86cc6985e2e467c145637d2a0a56040",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "NORTHAMPTON, MA / ACCESS Newswire / July 28, 2026 /Delivering Our Best for Every Patient Advancing equal access for all patients - regardless of demographic or social status - is central to DaVita's unwavering pursuit of a healthier tomorrow. In the ...",
                "category": "company",
                "datetime": 1785249900,
                "headline": "DaVita Community Care Report 2025 : Advancing Healthcare Access for Every Patient"
              },
              {
                "id": 141040721,
                "url": "https://finnhub.io/api/news?id=8534244f2ee1a181c4672eaee541ad645ae4e926018a71676fb9eca7bd7f598a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DVA",
                "summary": "New investor Horizon 3 Healthcare led the round, which was supported by the European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita and other current shareholders Builds on the €50m secured in 2025 and supports Xeltis’ next phase of clinical, regulatory and commercial executionAdditional €20.5m provides the runway to finalize the ongoing US pivotal trial of aXess™, prepare for FDA submission and US Go-To- Market, fund the European commercial rollout of aXess™, upscale manu",
                "category": "company",
                "datetime": 1785223800,
                "headline": "Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch"
              },
              {
                "id": 141013951,
                "url": "https://finnhub.io/api/news?id=fc11597c6346c291a7b659239030f6981c74d9757be3c5c75a0d6650221c1b9e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323206885/image_1323206885.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DVA",
                "summary": "DaVita (DVA) nears the high end of its historical valuation range, signaling possible overvaluation and mean reversion risk—monitor levels and consider...",
                "category": "company",
                "datetime": 1784942311,
                "headline": "Davita: Valuation Is Nearing Resistance Level"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 6,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 59,
            "discarded_article_count": 44
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11.7,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日5日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 882716.6666666666,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 678130,
              "avg_vol_20": 1020420,
              "avg_vol_30": 882716.6666666666,
              "range_pct_10": 0.07490084985835693,
              "range_pct_20": 0.4178470254957507,
              "range_pct_30": 0.4178470254957507,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7682306515869569,
              "dist_to_20d_high": 0.2868399011337872,
              "down_shrink_days": 5,
              "breakout_level_20d": 247.49001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.17925423728813558
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 4.4366572237960336,
              "turnoverUsdM": 194.582778,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DVA",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 160.8386,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.9,
            "take_profit_price": 191.3783,
            "target_multiplier": 1.9,
            "technical_strength": 1.5,
            "take_profit_percent": 8.4
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.873314447592067,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 7.8307,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.44
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -61.91
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.2557
    },
    "kdj": {
      "d": 10.17,
      "j": 30.2,
      "k": 16.85,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 23.42
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -532648,
      "recentSlope": 62075.2,
      "previousSlope": -951130
    },
    "rsi": 15.01,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 197.3494,
      "position": "SAR喺價上",
      "distancePct": 11.81,
      "previousTrend": "下降"
    },
    "ma50": 213.85,
    "macd": {
      "macd": -13.128586672388565,
      "trend": "看跌",
      "signal": -11.753515053673684,
      "histogram": -1.3750716187148804
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 198.355,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.06,
      "score": 6,
      "avgVolume": 1044268,
      "currentVolume": 1102452
    },
    "derived": {
      "ma20": 196.7185,
      "ma50": 213.85,
      "prevClose": 173.82,
      "avgVolume10": 709705,
      "avgVolume20": 1044268,
      "changePercent": 1.54,
      "avgVolumeForScore": 1044268
    },
    "ma_cross": {
      "ma20": 196.7185,
      "ma50": 213.85,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 199.709,
      "prevMa50": 214.3966,
      "spreadPct": 8.01,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 143.5647,
      "upper": 249.8723,
      "position": "中間"
    },
    "rsi_short": 34.3,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.06
    }
  }
}

{
  "close": 176.5,
  "volume": 1102452,
  "changePercent": 1.54
}